Justices Take Up Zicam Case, Questioning Maker on Disclosures to Investors
Tuesday, January 11, 2011 - 02:30
in Mathematics & Economics
Matrixx Initiatives is accused of securities fraud by failing to tell investors about reports of problems with Zicam, a nasal spray and gel product.